Short Course of Interferon Treatment in Patients With HCV Infection
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
To determine if a shorter course of interferon and ribavirin therapy will be sufficient in
carefully selected patients with chronic hepatitis C virus genotype 3 infection, as compared
to the standard length of treatment of 6 months.